Work

4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors

Year: 2008

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2008.07.020

Authors: Guozhang Xu, Marta C. Abad, Peter J. Connolly, Michael P. Neeper, Geoffrey T. Struble, Barry A. Springer, Stuart L. Emanuel, Niranjan Pandey, Robert H. Gruninger, Mary Adams, Sandra Moreno-Mazza, Angel R. Fuentes-Pesquera, Steven A. Middleton

Institutions: Johnson & Johnson (United States), Janssen Research & Development (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Institute of Microbiology, Chinese Academy of Sciences

OpenAlex ID: W2030547477

FWCI: 2.287

Cites: 13

Cited by: 87

Related to: 10